In our study, gene expression analyses show that S100A2, S100A11, and S100P expression levels in CRC tissues are significantly higher than those in noncancerous tissues, and S100A3 and S100A9 mRNAs are highly expressed in cancer tissues compared with normal tissue controls. This evidence concerns the gene S100A9 and colorectal carcinoma.